Tekla Capital Management LLC Sutro Biopharma, Inc. Call Options Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STRO
# of Institutions
122Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$17.6 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$17.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$14.4 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$12.5 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$9.22 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $159M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...